PLAU antibody (Plasminogen Activator, Urokinase) (C-Term)

Details for Product anti-PLAU Antibody No. ABIN2477037
Antigen
  • PLAU
  • u-PA
  • ATF
  • BDPLT5
  • QPD
  • UPA
  • URK
  • uPA
  • UPAM
  • plasminogen activator, urokinase
  • urokinase-type plasminogen activator
  • PLAU
  • CpipJ_CPIJ002131
  • CpipJ_CPIJ006543
  • CpipJ_CPIJ013396
  • CpipJ_CPIJ013623
  • Plau
Epitope
C-Term
21
10
9
8
4
4
3
3
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
Reactivity
Human
228
101
63
17
16
5
3
2
2
1
1
Host
Goat
194
68
58
16
2
Clonality
Polyclonal
Conjugate
This PLAU antibody is un-conjugated
34
28
14
7
6
5
2
2
2
2
2
2
1
1
Application
ELISA, Western Blotting (WB)
254
186
95
41
38
35
22
21
19
18
16
16
10
9
3
2
2
2
Options
Immunogen Peptide with sequence C-HFLPWIRSHTKEEN from the C-terminal of the Urokinase sequence.
Isotype IgG
Characteristics Purified IgG
Purification Purified
Plasmids, Primers & others Plasmids, Primers & others PLAU products on genomics-online (e.g. as negative or positive controls)
Antigen
Alternative Name UROKINASE (PLAU Antibody Abstract)
Gene ID 5328
UniProt P00749
Pathways Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagy, Smooth Muscle Cell Migration
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Liquid
Concentration 0.5 mg/mL
Product cited in: Mondino, Blasi: "uPA and uPAR in fibrinolysis, immunity and pathology." in: Trends in immunology, Vol. 25, Issue 8, pp. 450-5, 2004 (PubMed).

Did you look for something else?